What You Should Know:
- Glimmer Health, a new company designed to empower primary care physicians with effective and comprehensive chronic pain management solutions, was officially unveiled today by UPMC Enterprises and Redesign Health. This marks the second innovative healthcare company funded and launched through the partnership between the venture capital arm of UPMC and the New York-based company creator.
- Glimmer Health aims to address the significant burden of chronic pain,
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Veradigm Launches AI-Driven GLP-1 Dataset from EHR Data
What You Should Know:
- Veradigm, a provider of healthcare data and technology solutions, today announced a significant advancement in the application of artificial intelligence (AI) to scale the generation of real-world evidence (RWE) for the increasingly prevalent GLP-1 receptor agonists (GLP-1 RAs), including widely used medications like semaglutide and tirzepatide.
By deploying AI algorithms on deidentified electronic health record (EHR) data within the extensive Veradigm
Read More
Mentaily Secures $3M for AI-Powered Mental Health Assessment Tool, LIV
What You Should Know:
- Mentaily, a company developing AI-powered tools for mental health assessment, triage, and the diagnosis of mental disorders secures $3M seed funding round led by a US-based family office and Israeli family offices, with significant participation from impact funds The Rashi Foundation and Sheatufim, alongside prominent digital health angel investors.
- Founded in 2024, Mentaily is focused on addressing complex mental health needs, particularly those emerging in
Read More
Omada Health Files for IPO
What You Should Know:
- Virtual care company Omada Health filed for an initial public offering (IPO) on Friday, according to the SEC filing.
- Founded in 2012, Omada specializes in virtual care programs designed to support patients managing chronic conditions such as prediabetes, diabetes, and hypertension.
- The company describes its unique approach as a “between-visit care model,” aiming to complement the broader healthcare ecosystem by providing ongoing support to
Read More
Aranscia Acquires Spesana to Advance Precision Oncology
What You Should Know:
- Aranscia, a global provider of award-winning clinical workflow and diagnostic technology solutions announced its strategic acquisition of Spesana and its best-in-class suite of patient navigation, clinical collaboration, and oncology clinical decision support utilities.
- As part of the acquisition, Spesana’s Founder and CEO, Carla Balch, a renowned pioneer in healthcare and oncology information systems, will assume the role of Executive Director across
Read More
Cornerstone AI & Loopback Analytics to Optimize LOINC Codes in Lab Data
What You Should Know:
- Cornerstone AI, a pioneer in advanced data quality solutions, today announced a partnership with Loopback Analytics, a leading provider of data-enabled services and solutions for health system specialty pharmacies and life sciences companies.
- Announced ahead of the ISPOR 2025 conference, the collaboration will optimize the assignment of Logical Observation Identifiers Names and Codes (LOINC) across laboratory test results in Loopback Analytics’ EHR-based real
Read More
AI Study Challenges Fears of Racial Bias in Prostate Cancer Care
What You Should Know:
- Artera, a company developing multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announced the publication of a significant validation study in the JCO Clinical Cancer Informatics.
- The study rigorously assessed Artera's MMAI model and confirmed its ability to perform similarly across different racial subgroups using data from diverse prostate cancer clinical trials.
Addressing the Challenge of AI Racial Bias
Read More
FDA Approves Teal Wand™: The First At-Home Self-Collection Device for Cervical Cancer Screening in the U.S.
What You Should Know:
- Teal Health®, a women's health company dedicated to eliminating cervical cancer, today announced a landmark achievement: the U.S. Food and Drug Administration (FDA) has approved the Teal Wand™, marking it as the first and only at-home self-collection device for cervical cancer screening in the United States.
- The FDA approval paves the way for women to have a new, convenient, and effective option for what is commonly known as the Pap smear,
Read More
Beyond Patient Portals: Defining the Clinician Digital Front Door
First impressions are everything. Almost everyone working in healthcare understands that. And it’s not just clinicians. The architect who designed the front lobby of a hospital or the website developer who ensures the ease of use of a health system’s digital presence understands how important that first impression is. Patients come first in healthcare, and that’s true when focusing on patient access or simply creating a welcoming environment. It is just as important to focus on the impact that
Read More
AI Shows Promise in Detecting Overlooked Breast Cancers Between Screenings, UCLA Study Reveals
What You Should Know:
- Artificial intelligence (AI) could play a crucial role in identifying breast cancers that develop between routine screening mammograms, potentially detecting them before they become more advanced and challenging to treat, according to a new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center.
- The research suggests that integrating AI into breast cancer screening practices could lead to earlier treatment and improved
Read More
